Announce Date | 08/04/2025 |
EPS Normalized Actual | $1.02 (Beat by $0.23) |
EPS GAAP Actual | $1.02 (Beat by $0.23) |
Revenue Actual | $0.764039B |
Revenue Surprise | Beat by $764.039M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.82562 |
EPS GAAP Estimate | $0.82562 |
Revenue Estimate | $0.67468523B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 5.45 | 32 | 5.22512 | 5.58899 | 1 |
Dec 2028 | 0 | INF | 0 | 0 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.86 | 0.01457 | 0.764039B | 10.82% | 94.21M |
FQ1 2025 (Mar 2025) | 0.82 | 0.82 | 0.682258B | 11.48% | 682.26M |
FQ4 2024 (Dec 2024) | 0.78 | 0.78 | 0.746267B | 2.78% | 746.27M |
FQ3 2024 (Sep 2024) | 0.76 | 0.76 | 0.671956B | 12.2% | 671.96M |
FQ2 2024 (Jun 2024) | 0.8 | 0.8 | 0.68134B | 10.11% | 681.34M |
FQ1 2024 (Mar 2024) | 0.75 | 0.75 | 0.603966B | 5.9% | 603.97M |
FQ4 2023 (Dec 2023) | 0.72 | 0.72 | 0.725507B | 13.97% | 725.51M |
FQ3 2023 (Sep 2023) | 0.66 | 0.66 | 0.589989B | 11.23% | 589.99M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.82562
Consensus Revenue Estimates
0.67468523B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.35326 | -- | 1.27453 | 1.4377 | 2 |
FQ3 2027 (Sep 2027) | 1.09505 | -- | 1.02757 | 1.20962 | 1 |
FQ2 2027 (Jun 2027) | 1.10805 | -- | 1.03977 | 1.22398 | 1 |
FQ1 2027 (Mar 2027) | 0.94252 | -- | 0.88444 | 1.04113 | 1 |
FQ4 2026 (Oct 2026) | 1.01845 | -- | 0.99746 | 1.03893 | 0 |
FQ3 2026 (Jul 2026) | 0.99089 | -- | 0.97047 | 1.01082 | 0 |
FQ2 2026 (Jun 2026) | 1.00553 | 14.47 | 0.99097 | 1.01776 | 1 |
FQ1 2026 (Mar 2026) | 0.86853 | 5.59 | 0.85595 | 0.87909 | 1 |
FQ4 2025 (Oct 2025) | 0.84919 | 8.15 | 0.83169 | 0.86627 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.01B | -- | 0.96B | 1.05B | 8 |
FQ3 2027 (Sep 2027) | 0.91B | -- | 0.87B | 0.98B | 2 |
FQ2 2027 (Jun 2027) | 0.91B | -- | 0.86B | 0.98B | 2 |
FQ1 2027 (Mar 2027) | 0.82B | -- | 0.78B | 0.88B | 2 |
FQ4 2026 (Oct 2026) | 0.74B | -- | 0.73B | 0.75B | 1 |
FQ3 2026 (Jul 2026) | 0.73B | -- | 0.72B | 0.74B | 1 |
FQ2 2026 (Jun 2026) | 0.72B | -5.78 | 0.71B | 0.73B | 2 |
FQ1 2026 (Mar 2026) | 0.65B | -4.5 | 0.65B | 0.66B | 2 |
FQ4 2025 (Oct 2025) | 0.68B | -9.13 | 0.67B | 0.69B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.84543 | 0.86 | 0.01457 | 1.69% |
FQ1 2025 (Mar 2025) | 0.82 | 0.82 | 100% | |
FQ4 2024 (Dec 2024) | 0.78 | 0.78 | 100% | |
FQ3 2024 (Sep 2024) | 0.76 | 0.76 | 100% | |
FQ2 2024 (Jun 2024) | 0.8 | 0.8 | 100% | |
FQ1 2024 (Mar 2024) | 0.75 | 0.75 | 100% | |
FQ4 2023 (Dec 2023) | 0.72 | 0.72 | 100% | |
FQ3 2023 (Sep 2023) | 0.66 | 0.66 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.67B | $0.76B | $94.21M | 12.33% |
FQ1 2025 (Mar 2025) | $0B | $0.68B | $682.26M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.75B | $746.27M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.67B | $671.96M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.68B | $681.34M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.6B | $603.97M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.73B | $725.51M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.59B | $589.99M | 100% |